De novo mutational signature discovery in tumor genomes using SparseSignatures.
Cancer is the result of mutagenic processes that can be inferred from tumor genomes by analyzing rate spectra of point mutations, or "mutational signatures". Here we present SparseSignatures, a novel framework to extract signatures from somatic point mutation data. Our approach incorporate...
Guardado en:
Autores principales: | Avantika Lal, Keli Liu, Robert Tibshirani, Arend Sidow, Daniele Ramazzotti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed06227f6ba944be9baaed2c108694e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival
por: Daniele Ramazzotti, et al.
Publicado: (2018) -
A mixture model for signature discovery from sparse mutation data
por: Itay Sason, et al.
Publicado: (2021) -
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
por: Harald Vöhringer, et al.
Publicado: (2021) -
Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis
por: Huiyong Xu, et al.
Publicado: (2021) -
Mutational signatures of ionizing radiation in second malignancies
por: Sam Behjati, et al.
Publicado: (2016)